{"prompt": "['Abbott', 'Clinical Investigation Plan (CIP)', 'Prospective One-Center Clinical Approbation Assessment', 'of The Symptomatic Chronic Severe Mitral Regurgitation', 'Treatment with', 'MitraClip NT System', 'Redacted Version B', 'Nov 15, 2021', '2019']['MitraClip NT System', 'Clinical Investigation Plan Version: 1.0', 'Abbott', 'Protocol Name and', 'ABT-CIP 10334 Version 1.0', 'Version Number', 'Date', '13 December 2019', 'Coordinating Clinical', '(Chief Researcher, Doctor of Medical', 'Investigator/Study Principal', 'Sciences, Head of the Laboratory of Hybrid Methods of the', 'Investigator:', 'Treatment of Cardiovascular Diseases)', 'Study Co-Principal Investigator', '1 Site:', 'Federal State Budgetary Institution \"National Medical Research', 'Planned Number of Sites and', 'Center of Cardiology\" of the Ministry of Health of the Russian', 'Region(s)', 'Federation (short name - FSBI \"NICC of Cardiology\" of the Ministry', 'of Health of Russia).', 'Address: 121552, Moscow, st. 3rd Cherepkovskaya, d.15A.', 'Clinical Investigation Type', 'A prospective, single-center study', 'Limited Liability Company ABBOTT LABORATORIES', 'Sponsor', '(LLC \"ABBOTT LABORATORIES\")', '125171, Russia, Moscow, Leningrad highway 16A, building 1', 'Tel.: +7 (495) 258 42 80/81', 'CIP Author of Current Version', 'Page 2 from 61']['MitraClip NT System', 'Clinical Investigation Plan Version: 1.0', 'Abbott', 'SITE PRINCIPAL INVESTIGATOR SIGNATURE PAGE', 'I have read and agree to adhere to the clinical investigation plan and all regulatory requirements applicable', 'in conducting this clinical investigation.', 'Site Principal Investigator', 'Printed name:', 'Signature:', 'Date:', 'Page 3 from 61']\n\n###\n\n", "completion": "END"}